Sara A. Wahdan

1.2k total citations · 1 hit paper
32 papers, 753 citations indexed

About

Sara A. Wahdan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Sara A. Wahdan has authored 32 papers receiving a total of 753 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 6 papers in Genetics. Recurrent topics in Sara A. Wahdan's work include Cancer-related cognitive impairment studies (9 papers), Brain Metastases and Treatment (5 papers) and Glioma Diagnosis and Treatment (4 papers). Sara A. Wahdan is often cited by papers focused on Cancer-related cognitive impairment studies (9 papers), Brain Metastases and Treatment (5 papers) and Glioma Diagnosis and Treatment (4 papers). Sara A. Wahdan collaborates with scholars based in Egypt. Sara A. Wahdan's co-authors include Samar S. Azab, Ebtehal El‐Demerdash, Doaa A. Elsherbiny, Amany M. Gad, Maha Nasr, Amal Kamal Abdel‐Aziz, Ahmed Esmat, Marwa O. El-Derany, Reem N. El‐Naga and Hala O. El‐Mesallamy and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Life Sciences.

In The Last Decade

Sara A. Wahdan

31 papers receiving 745 citations

Hit Papers

Insights on the crosstalk... 2025 2026 2025 5 10 15 20 25
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Insights on the crosstalk among different cell death mechanisms
    2025 25 citations Sherihan G. AbdelHamid, Sara A. Wahdan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara A. Wahdan Egypt 15 235 210 109 87 66 32 753
Zhong‐Ming Qian China 18 101 0.4× 317 1.5× 123 1.1× 64 0.7× 34 0.5× 34 847
Wei Ji China 18 80 0.3× 236 1.1× 47 0.4× 63 0.7× 86 1.3× 67 828
Wael A. Alanazi Saudi Arabia 18 98 0.4× 394 1.9× 37 0.3× 56 0.6× 135 2.0× 40 1.1k
Sharon Williams‐Ignarro Italy 19 133 0.6× 427 2.0× 104 1.0× 139 1.6× 86 1.3× 22 1.6k
Xiaohong Chen China 16 139 0.6× 295 1.4× 18 0.2× 88 1.0× 69 1.0× 43 871
Zhenhua Shi China 17 158 0.7× 317 1.5× 53 0.5× 49 0.6× 44 0.7× 35 833
Sang‐Won Hong South Korea 14 42 0.2× 311 1.5× 91 0.8× 116 1.3× 113 1.7× 23 878
Vincenzo Trichilo Italy 13 78 0.3× 438 2.1× 35 0.3× 67 0.8× 25 0.4× 15 962
Marawan A. Elbaset Egypt 18 47 0.2× 220 1.0× 38 0.3× 142 1.6× 45 0.7× 70 803

Countries citing papers authored by Sara A. Wahdan

Since Specialization
Citations

This map shows the geographic impact of Sara A. Wahdan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara A. Wahdan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara A. Wahdan more than expected).

Fields of papers citing papers by Sara A. Wahdan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara A. Wahdan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara A. Wahdan. The network helps show where Sara A. Wahdan may publish in the future.

Co-authorship network of co-authors of Sara A. Wahdan

This figure shows the co-authorship network connecting the top 25 collaborators of Sara A. Wahdan. A scholar is included among the top collaborators of Sara A. Wahdan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara A. Wahdan. Sara A. Wahdan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
AbdelHamid, Sherihan G., et al.. (2025). Roflumilast attenuates doxorubicin and cyclophosphamide combination-induced chemobrain in rats through modulation of NLRP3/ASC/caspase-1/GSDMD axis. Life Sciences. 362. 123378–123378. 1 indexed citations
3.
Abdelsameea, Eman, et al.. (2025). Unveiling the nexus between direct-acting antivirals in hepatitis C virus elimination and immune response. Clinical and Experimental Medicine. 25(1). 269–269.
4.
5.
6.
El-Derany, Marwa O., et al.. (2023). The role of mitochondrial/metabolic axis in development of tamoxifen resistance in breast cancer. Human Cell. 36(6). 1877–1886. 5 indexed citations
7.
Wahdan, Sara A., et al.. (2023). Insights into the therapeutic outcomes of trimetazidine/doxorubicin combination in Ehrlich solid-phase carcinoma mouse tumor model. Life Sciences. 328. 121874–121874. 2 indexed citations
8.
Wahdan, Sara A., et al.. (2022). Effects of aged garlic and ginkgo biloba extracts on the pharmacokinetics of sofosbuvir in rats. Biopharmaceutics & Drug Disposition. 43(4). 152–162. 3 indexed citations
9.
Wahdan, Sara A., et al.. (2022). Effect of Atorvastatin on Single Oral Pharmacokinetics and Safety of Daclatasvir inRats: Emphasis on P-glycoprotein and Cytochrome P450. Current Drug Metabolism. 23(6). 484–495. 4 indexed citations
10.
Wahdan, Sara A., Doaa A. Elsherbiny, Samar S. Azab, & Ebtehal El‐Demerdash. (2021). Piceatannol ameliorates behavioural, biochemical and histological aspects in cisplatin‐induced peripheral neuropathy in rats. Basic & Clinical Pharmacology & Toxicology. 129(6). 486–495. 9 indexed citations
11.
Wahdan, Sara A., et al.. (2021). Saxagliptin ameliorated the depressive-like behavior induced by chronic unpredictable mild stress in rats: Impact on incretins and AKT/PI3K pathway. European Journal of Pharmacology. 912. 174602–174602. 16 indexed citations
12.
Wahdan, Sara A., et al.. (2021). Hepatitis C virus infection: Epidemiology in Egypt, Pathophysiology and DAAs-based therapy. 5(2). 234–248. 1 indexed citations
13.
El‐Naga, Reem N., et al.. (2021). Neuroprotective effects of indole-3-carbinol on the rotenone rat model of Parkinson's disease: Impact of the SIRT1-AMPK signaling pathway. Toxicology and Applied Pharmacology. 435. 115853–115853. 32 indexed citations
14.
Radwan, Sara M., et al.. (2020). Adipose Tissue–Derived Mesenchymal Stem Cells Protect Against Amiodarone-Induced Lung Injury in Rats. Applied Biochemistry and Biotechnology. 191(3). 1027–1041. 15 indexed citations
15.
Wahdan, Sara A., et al.. (2020). Chemotherapy-induced cognitive impairment (CICI): An overview of etiology and pathogenesis. Life Sciences. 378. 118071–118071. 89 indexed citations
16.
Wahdan, Sara A., et al.. (2020). Abrogating doxorubicin-induced chemobrain by immunomodulators IFN-beta 1a or infliximab: Insights to neuroimmune mechanistic hallmarks. Neurochemistry International. 138. 104777–104777. 22 indexed citations
17.
Wahdan, Sara A., et al.. (2020). Diosmin ameliorates inflammation, insulin resistance, and fibrosis in an experimental model of non-alcoholic steatohepatitis in rats. Toxicology and Applied Pharmacology. 401. 115101–115101. 29 indexed citations
18.
Nasr, Maha & Sara A. Wahdan. (2019). Neuroprotective effects of novel nanosystems simultaneously loaded with vinpocetine and piracetam after intranasal administration. Life Sciences. 226. 117–129. 58 indexed citations
19.
Gad, Amany M., et al.. (2019). Efficacy and safety of Ramucirumab and methotrexate co-therapy in rheumatoid arthritis experimental model: Involvement of angiogenic and immunomodulatory signaling. Toxicology and Applied Pharmacology. 380. 114702–114702. 23 indexed citations
20.
Abdel‐Aziz, Amal Kamal, et al.. (2017). Astaxanthin Ameliorates Doxorubicin-Induced Cognitive Impairment (Chemobrain) in Experimental Rat Model: Impact on Oxidative, Inflammatory, and Apoptotic Machineries. Molecular Neurobiology. 55(7). 5727–5740. 127 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhong‐Ming Qian Breakdown of academic impact, for papers by Wei Ji Breakdown of academic impact, for papers by Wael A. Alanazi Breakdown of academic impact, for papers by Sharon Williams‐Ignarro Breakdown of academic impact, for papers by Xiaohong Chen Breakdown of academic impact, for papers by Zhenhua Shi Breakdown of academic impact, for papers by Sang‐Won Hong Breakdown of academic impact, for papers by Vincenzo Trichilo Breakdown of academic impact, for papers by Marawan A. Elbaset
Rankless by CCL
2026